Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls-preliminary findings

Psychiatry Research - Neuroimaging

Volumn 224, Issue 3, 2014, Pages 168-174

  Lindqvist, Daniel ^a,b   Mueller, Susanne ^a,c   Mellon, Synthia H ^a   Su, Yali ^d,e   Epel, Elissa S ^a   Reus, Victor I ^a   Rosser, Rebecca ^a   Mahan, Laura ^a   Scott Mackin, R ^a,c   Yang, Tony T ^a   Wolkowitz, Owen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LUND UNIVERSITY   (Sweden)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SilverCreek Technologies   (United States)

^e GE GLOBAL RESEARCH   (United States)

Author keywords

Aging; Glutathione; Hippocampus; Oxidative Stress; Subfields; Vitamin C

Indexed keywords

ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; BIOLOGICAL MARKER;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HUMAN; MAJOR DEPRESSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OXIDATIVE STRESS; PRIORITY JOURNAL; SCORING SYSTEM; SUBICULUM; BLOOD; HIPPOCAMPUS; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADULT; BIOMARKERS; CA3 REGION, HIPPOCAMPAL; DENTATE GYRUS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 84945486783     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2014.09.002     Document Type: Article

References (39)

1. Babyak, M.A., 2004. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosomatic Medicine 66, 411-421.
2. Bearden, C.E., Thompson, P.M., Avedissian, C., Klunder, A.D., Nicoletti, M., Dierschke, N., Brambilla, P., Soares, J.C., 2009. Altered hippocampal morphology in unmedicated patients with major depressive illness. ASN Neuro 1, 265-273.http://dx.doi.org/10.1042/AN20090026.
3. Behr, G.A., Moreira, J.C., Frey, B.N., 2012. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxidative Medicine and Cellular Longevity 2012, 609421.
4. Bender, R., Lange, S., 2001. Adjusting for multiple testing-when and how? Journal of Clinical Epidemiology 54, 343-349.
5. Berk, M., Ng, F., Dean, O., Dodd, S., Bush, A.I., 2008. Glutathione: a novel treatment target in psychiatry. Trends in Pharmacological Sciences 29, 346-351.
6. Chang, B.J., Jang, B.J., Son, T.G., Cho, I.H., Quan, F.S., Choe, N.H., Nahm, S.S., Lee, J.H., 2012. Ascorbic acid ameliorates oxidative damage induced by maternal lowlevel lead exposure in the hippocampus of rat pups during gestation and lactation. Food and Chemical Toxicology 50, 104-108.
7. Che, Y., Wang, J.F., Shao, L., Young, T., 2010. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. Journal of Psychiatry and Neuroscience 35, 296-302.
8. Cruz-Sanchez, F.F., Girones, X., Ortega, A., Alameda, F., Lafuente, J.V., 2010. Oxidative stress in Alzheimer's disease hippocampus: a topographical study. Journal of the Neurological Sciences 299, 163-167.
9. Dhabhar, F.S., Burke, H.M., Epel, E.S., Mellon, S.H., Rosser, R., Reus, V.I., Wolkowitz, O.M., 2009. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. Journal of Psychiatric Research 43, 962-969.
10. Dringen, R., Hirrlinger, J., 2003. Glutathione pathways in the brain. Biological Chemistry 384, 505-516.
11. Eriksson, S.H., Thom, M., Bartlett, P.A., Symms, M.R., McEvoy, A.W., Sisodiya, S.M., Duncan, J.S., 2008. PROPELLER MRI visualizes detailed pathology of hippocampal sclerosis. Epilepsia 49, 33-39.
12. Evans, P.H., 1993. Free radicals in brain metabolism and pathology. British Medical Bulletin 49, 577-587.
13. Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N., Rosen, B., Dale, A.M., 2002. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355.
14. Flohe, L., 1971. Glutathione peroxidase: enzymology and biological aspects. Klinische Wochenschrift 49, 669-683.
15. Fraguas, D., Gonzalez-Pinto, A., Mico, J.A., Reig, S., Parellada, M., MartinezCengotitabengoa, M., Castro-Fornieles, J., Rapado-Castro, M., Baeza, I., Janssen, J., Desco, M., Leza, J.C., Arango, C., 2012. Decreased glutathione levels predict loss of brain volume in children and adolescents withfirst-episode psychosis in a two-year longitudinal study. Schizophrenia Research 137, 58-65.
16. Gawryluk, J.W., Wang, J.F., Andreazza, A.C., Shao, L., Young, L.T., 2011. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. The International Journal of Neuropsychopharmacology 14, 123-130.
17. Ghosh, N., Ghosh, R., Mandal, S.C., 2011. Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease. Free Radical Research 45, 888-905.
18. Hickie, I., Naismith, S., Ward, P.B., Turner, K., Scott, E., Mitchell, P., Wilhelm, K., Parker, G., 2005. Reduced hippocampal volumes and memory loss in patients with early-and late-onset depression. The British Journal of Psychiatry 186, 197-202.
19. Huang, T.T., Zou, Y., Corniola, R., 2012. Oxidative stress and adult neurogenesis-effects of radiation and superoxide dismutase deficiency. Seminars in Cell & Developmental Biology 23, 738-744.
20. Huang, Y., Coupland, N.J., Lebel, R.M., Carter, R., Seres, P., Wilman, A.H., Malykhin, N.V., 2013. Structural changes in hippocampal subfields in major depressive disorder: a high-field magnetic resonance imaging study. Biological Psychiatry 74, 62-68.
21. Lee, J.Y., Chang, M.Y., Park, C.H., Kim, H.Y., Kim, J.H., Son, H., Lee, Y.S., Lee, S.H., 2003. Ascorbate-induced differentiation of embryonic cortical precursors into neurons and astrocytes. Journal of Neuroscience Research 73, 156-165.
22. Lubos, E., Loscalzo, J., Handy, D.E., 2011. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxidants & Redox Signaling 15, 1957-1997.
23. Margolis, S.A., Schapira, R.M., 1997. Liquid chromatographic measurement of L-ascorbic acid and D-ascorbic acid in biological samples. Journal of Chromatography B: Biomedical Sciences and Applications 690, 25-33.
24. Mattson, M.P., 2000. Apoptosis in neurodegenerative disorders. Nature Reviews Molecular Cell Biology 1, 120-129.
25. McKinnon, M.C., Yucel, K., Nazarov, A., MacQueen, G.M., 2009. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. Journal of Psychiatry and Neuroscience 34, 41-54.
26. Mueller, S.G., Schuff, N., Yaffe, K., Madison, C., Miller, B., Weiner, M.W., 2010. Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Human Brain Mapping 31, 1339-1347.
27. Mueller, S.G., Stables, L., Du, A.T., Schuff, N., Truran, D., Cashdollar, N., Weiner, M.W., 2007. Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4 T. Neurobiology of Aging 28, 719-726.
28. Ng, F., Berk, M., Dean, O., Bush, A.I., 2008. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. The International Journal of Neuropsychopharmacology 11, 851-876.
29. Posener, J.A., Wang, L., Price, J.L., Gado, M.H., Province, M.A., Miller, M.I., Babb, C.M., Csernansky, J.G., 2003. High-dimensional mapping of the hippocampus in depression. The American Journal of Psychiatry 160, 83-89.
30. Qiu, S., Li, L., Weeber, E.J., May, J.M., 2007. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. The Journal of Neuroscience Research 85, 1046-1056.
31. Quinn, J., Suh, J., Moore, M.M., Kaye, J., Frei, B., 2003. Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain. Journal of Alzheimer's Disease 5, 309-313.
32. Rawdin, B.J., Mellon, S.H., Dhabhar, F.S., Epel, E.S., Puterman, E., Su, Y., Burke, H.M., Reus, V.I., Rosser, R., Hamilton, S.P., Nelson, J.C., Wolkowitz, O.M., 2013. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behavior, and Immunity 31, 143-152.
33. Sadowski, M., Wisniewski, H.M., Jakubowska-Sadowska, K., Tarnawski, M., Lazarewicz, J.W., Mossakowski, M.J., 1999. Pattern of neuronal loss in the rat hippocampus following experimental cardiac arrest-induced ischemia. Journal of the Neurological Sciences 168, 13-20.
34. Sashindranath, M., McLean, K.J., Trounce, I.A., Cotton, R.G., Cook, M.J., 2010. Early hippocampal oxidative stress is a direct consequence of seizures in the rapid electrical amygdala kindling model. Epilepsy Research 90, 285-294.
35. Steullet, P., Cabungcal, J.H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T.P., Cuenod, M., Do, K.Q., 2010. Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. The Journal of Neuroscience 30, 2547-2558.
36. Tveden-Nyborg, P., Johansen, L.K., Raida, Z., Villumsen, C.K., Larsen, J.O., Lykkesfeldt, J., 2009. Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. The American Journal of Clinical Nutrition 90, 540-546.
37. Uysal, N., Tugyan, K., Aksu, I., Ozbal, S., Ozdemir, D., Dayi, A., Gonenc, S., Acikgoz, O., 2012. Age-related changes in apoptosis in rat hippocampus induced by oxidative stress. Biotechnic Histochemistry 87, 98-104.
38. Wolkowitz, O.M., Mellon, S.H., Epel, E.S., Lin, J., Dhabhar, F.S., Su, Y., Reus, V.I., Rosser, R., Burke, H.M., Kupferman, E., Compagnone, M., Nelson, J.C., Blackburn, E.H., 2011. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress-preliminaryfindings. PLoS One 6, e17837.
39. Wolkowitz, O.M., Mellon, S.H., Epel, E.S., Lin, J., Reus, V.I., Rosser, R., Burke, H., Compagnone, M., Nelson, J.C., Dhabhar, F.S., Blackburn, E.H., 2012. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Molecular Psychiatry 17, 164-172.